Vinpocetine Covex 5 mg improves cerebral blood flow, decreases cerebral vascular oxygen and glucose utilization. Vinpocetine Covex 5 mg inhibits phosphodiesterase activity, prevent platelet aggregation and adenosine intake by erythrocytes.
It diminishes or suppresses disturbances due to hypoxia or deficient cerebral metabolism.
Capillary under the effects of Vinpocetine
The finished dosage form of Vinpocetine (Vinpocetine Covex 5 mg) is marketed as a prescription product in Azerbaijan, Armenia, Belarus, Bulgaria, Cuba, Georgia, Hungary, Kazakhstan, Latvia, Lithuania, Mongolia, Portugal, Czech Republic, Slovakia, Spain, Russia, Ukraine.
